Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
17%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
CANC
48
HOLDINGS
21%
ALSO IN BBP
BBP
65
HOLDINGS
16%
ALSO IN CANC
SECTOR DRIFT (CANC minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
BEIGENE LTD. SPONSORED ADR | 2.6% | 2.3% | 2.3% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 2.8% | 2.2% | 2.2% |
|
AMGEN INC | 3.3% | 2.0% | 2.0% |
|
BRIDGEBIO PHARMA, INC. | 4.8% | 1.9% | 1.9% |
|
EXELIXIS INC | 4.0% | 1.8% | 1.8% |
CANC Overweight Relative to BBP
 |
ROCHE HOLDINGS LTD-SPONS ADR | 5.1% |
|
ELI LILLY & CO | 5.0% |
|
REVOLUTION MEDICINES, INC. | 4.7% |
|
NOVARTIS AG | 4.2% |
 |
ASTRAZENECA PLC | 3.9% |
 |
MERUS N.V. | 3.7% |
 |
GENMAB A/S SPONSORED ADR | 3.7% |
|
SUMMIT THERAPEUTICS INC | 3.5% |
|
NUVALENT, INC. CLASS A | 3.4% |
|
BRISTOL-MYERS SQUIBB CO | 3.3% |
CANC Underweight Relative to BBP
|
INTRA-CELLULAR THERAPIES INC | -2.6% |
|
SAGE THERAPEUTICS INC | -2.2% |
|
AXSOME THERAPEUTICS, INC. | -2.1% |
|
SPRINGWORKS THERAPEUTICS, INC. | -2.1% |
|
HALOZYME THERAPEUTICS INC | -2.1% |
|
TG THERAPEUTICS INC | -2.1% |
|
ASCENDIS PHARMA A/S | -1.8% |
|
PTC THERAPEUTICS INC | -1.8% |
|
DYNAVAX TECHNOLOGIES CORP | -1.8% |
|
MADRIGAL PHARMACEUTICALS, INC. | -1.8% |